Hyaluronidase product hailed as welcome revival of old drug

Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

A conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.

From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.

Researchers explore the unification of outpatient practices and the structural racism in large health systems that has caused patient disparities.

This white paper aims to delve deeper into the three pivotal strategies of driving purchasing compliance–contracts, agreements and regulations, providing insightful strategies and tools for navigating the pharmaceutical procurement process.